DAVID STEINER: Open Payments
NPI 1972508802 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 78 payments from 15 companies in 2025. Trend: 2023 $1,394 · 2024 $1,508 · 2025 $1,739
Food & beverage: $1,640Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $262 |
| ABBVIE INC. | 7 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $195 |
| Axsome Therapeutics, Inc. | 8 | $173 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $154 |
| Neurocrine BioSciences, Inc. | 5 | $142 |
| E.R. Squibb & Sons, L.L.C. | 6 | $138 |
| Alkermes, Inc. | 4 | $82 |
| Lundbeck LLC | 3 | $62 |
Products named: REXULTI, VRAYLAR, CAPLYTA, TRINTELLIX, INGREZZA, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
